dextropropoxyphene has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cabanillas, F; Callendar, D; Hagemeister, F; Mansfield, P; McLaughlin, P; Mesina, O; Moore, D; North, L; Rodriguez, MA; Romaguera, J; Sarris, AH; Swan, F; Younes, A | 1 |
1 trial(s) available for dextropropoxyphene and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cimetidine; Cross-Over Studies; Cyclosporine; Dexamethasone; Dextropropoxyphene; Diphenhydramine; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Membrane Glycoproteins; Middle Aged; Neoplasm Proteins; Paclitaxel; Premedication; Recurrence; Remission Induction | 1996 |